Merck vows to press ahead with Vioxx defense
12th Sep 2005, 03:16 GMT
NEW YORK (Reuters) - On the eve of a second court battle over its arthritis drug Vioxx, Merck & Co. Inc. said on Friday it does not plan to enter into any global settlement of the thousands of Vioxx lawsuits it faces and is focused on "defending these cases one at a time."
Latest news from Reuters: Health:
- Blow to chest can be fatal in child athletes: study
- Two Canada professors win right to toke up at work
- Diabetes drug may cut heart risks: study
- Most U.S. women in the dark about HPV: survey
- Red meat linked to some breast cancers: study
- Weight-loss surgery safety varies drastically: study
- Flu shot linked to tiny rise in risk for ailment
- Human natural painkiller beats morphine: research
- Radioactive iodine linked to thyroid disease
- Children showing hardening of arteries: study